Gliquidone

Gliquidone
Clinical data
Trade names Glurenorm
AHFS/Drugs.com International Drug Names
Pregnancy
category
  • C
Routes of
administration
Oral (tablets)
ATC code A10BB08 (WHO)
Legal status
Legal status
  • UK: POM (Prescription only)
  • ℞ (Prescription only)
Pharmacokinetic data
Bioavailability High (Tmax = 2–3 hours)
Metabolism Extensive hepatic
Onset of action 1–1.5 hours
Excretion Biliary (95%), renal (5%)
Identifiers
CAS Number 33342-05-1
PubChem (CID) 91610
DrugBank DB01251 YesY
ChemSpider 82719 YesY
UNII C7C2QDD75P YesY
KEGG D02430 YesY
ChEMBL CHEMBL383634 YesY
ECHA InfoCard 100.046.770
Chemical and physical data
Formula C27H33N3O6S
Molar mass 527.634 g/mol
3D model (Jmol) Interactive image
  (verify)

Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).

Contraindications

Pharmacokinetics

Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients suffering from kidney disease and diabetic nephropathy.[1]

References

  1. 1 2 "Glurenorm (gliquidone) 30 mg Tablets, for Oral Use. Full Prescribing Information". Russian State Register of Medicinal Products (in Russian). Boehringer Ingelheim. Retrieved 12 July 2016.
This article is issued from Wikipedia - version of the 8/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.